Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients
Clinical trial NCT04838821 · UNKNOWN
Trial details
- NCT number
- NCT04838821
- Sponsor
- Caja Costarricense de Seguro Social
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2021-07-29
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.